JPWO2021095874A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021095874A5
JPWO2021095874A5 JP2021556191A JP2021556191A JPWO2021095874A5 JP WO2021095874 A5 JPWO2021095874 A5 JP WO2021095874A5 JP 2021556191 A JP2021556191 A JP 2021556191A JP 2021556191 A JP2021556191 A JP 2021556191A JP WO2021095874 A5 JPWO2021095874 A5 JP WO2021095874A5
Authority
JP
Japan
Prior art keywords
alkyl
amino
group
chloride
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021556191A
Other languages
English (en)
Japanese (ja)
Other versions
JP7689078B2 (ja
JPWO2021095874A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/042505 external-priority patent/WO2021095874A1/ja
Publication of JPWO2021095874A1 publication Critical patent/JPWO2021095874A1/ja
Publication of JPWO2021095874A5 publication Critical patent/JPWO2021095874A5/ja
Priority to JP2025087141A priority Critical patent/JP2025128175A/ja
Application granted granted Critical
Publication of JP7689078B2 publication Critical patent/JP7689078B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021556191A 2019-11-13 2020-11-13 オリゴ核酸化合物の製造方法 Active JP7689078B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025087141A JP2025128175A (ja) 2019-11-13 2025-05-26 オリゴ核酸化合物の製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019205625 2019-11-13
JP2019205625 2019-11-13
PCT/JP2020/042505 WO2021095874A1 (ja) 2019-11-13 2020-11-13 オリゴ核酸化合物の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025087141A Division JP2025128175A (ja) 2019-11-13 2025-05-26 オリゴ核酸化合物の製造方法

Publications (3)

Publication Number Publication Date
JPWO2021095874A1 JPWO2021095874A1 (https=) 2021-05-20
JPWO2021095874A5 true JPWO2021095874A5 (https=) 2023-11-16
JP7689078B2 JP7689078B2 (ja) 2025-06-05

Family

ID=75913043

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021556191A Active JP7689078B2 (ja) 2019-11-13 2020-11-13 オリゴ核酸化合物の製造方法
JP2025087141A Pending JP2025128175A (ja) 2019-11-13 2025-05-26 オリゴ核酸化合物の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025087141A Pending JP2025128175A (ja) 2019-11-13 2025-05-26 オリゴ核酸化合物の製造方法

Country Status (7)

Country Link
US (1) US12600743B2 (https=)
EP (1) EP4059944A4 (https=)
JP (2) JP7689078B2 (https=)
KR (1) KR20220098217A (https=)
CN (1) CN114981281A (https=)
CA (1) CA3161586A1 (https=)
WO (1) WO2021095874A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240254158A1 (en) * 2021-04-28 2024-08-01 Nippon Shinyaku Co., Ltd. Method for producing oligonucleic acid compound
CA3244382A1 (en) * 2021-12-27 2025-02-26 Nippon Shinyaku Co., Ltd. PROCESS FOR THE PRODUCTION OF OLIGONUCLEIC ACID COMPOUNDS

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2130844A5 (https=) 1971-03-23 1972-11-10 Commissariat Energie Atomique
JPS5668388A (en) 1979-11-10 1981-06-09 Norin Suisansyo Shokuhin Sogo Kenkyusho Production of cell body of spirulina algae
JP3398378B2 (ja) 1989-12-20 2003-04-21 アンチビラルス・インコーポレイテツド リン含有キラルインターサブユニットリンケージを有する非電荷モルホリノ―基体ポリマー
JPH10109994A (ja) * 1996-10-03 1998-04-28 Sumitomo Chem Co Ltd アミドチオリン酸エステル誘導体の製造方法
US6313301B1 (en) 1997-08-13 2001-11-06 Takeda Chemical Industries, Ltd. Thienopyridine derivatives, their intermediates and production thereof
JPH1180185A (ja) 1997-09-05 1999-03-26 Res Dev Corp Of Japan オリゴヌクレオチドの化学合成法
US6274725B1 (en) * 1998-06-02 2001-08-14 Isis Pharmaceuticals, Inc. Activators for oligonucleotide synthesis
AU2002328792A1 (en) * 2001-07-12 2003-01-29 Santaris Pharma A/S Method for preparation of lna phosphoramidites
JP2005529957A (ja) 2002-06-13 2005-10-06 ローディア インク. リン・ジアミダイト合成物を生成する工程
US8067571B2 (en) * 2005-07-13 2011-11-29 Avi Biopharma, Inc. Antibacterial antisense oligonucleotide and method
KR20100022470A (ko) * 2007-05-22 2010-03-02 기린두스 아게 올리고뉴클레오타이드의 합성
KR100886139B1 (ko) 2007-11-13 2009-02-27 주식회사 삼천리제약 올리고뉴클레오타이드의 제조방법
MX2010004955A (es) 2007-11-15 2010-06-30 Avi Biopharma Inc Metodo de sintesis de oligomeros de morfolina.
JP5548852B2 (ja) 2009-05-29 2014-07-16 国立大学法人東京農工大学 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法
RS55610B1 (sr) 2010-09-30 2017-06-30 Nippon Shinyaku Co Ltd Derivat morfolino nukleinske kiseline
JP5979139B2 (ja) 2011-05-17 2016-08-24 味の素株式会社 オリゴヌクレオチドの製造方法
EA202090338A1 (ru) 2011-11-18 2021-04-30 Сарепта Терапьютикс, Инк. Функционально-модифицированные олигонуклеотиды и их субъединицы
US10066228B2 (en) 2011-11-30 2018-09-04 Sarepta Therapeutics, Inc. Oligonucleotides for treating expanded repeat diseases
EP2816053B1 (en) 2012-02-17 2021-03-24 Ajinomoto Co., Inc. Base-protected oligonucleotide
EP2921499B1 (en) 2012-11-14 2020-01-22 Takeda Pharmaceutical Company Limited Method for liquid-phase synthesis of nucleic acids
WO2014189142A1 (ja) 2013-05-24 2014-11-27 味の素株式会社 モルフォリノオリゴヌクレオチドの製造方法
JP6673211B2 (ja) 2014-10-14 2020-03-25 味の素株式会社 モルフォリノオリゴヌクレオチドの製造方法
EP3266792B1 (en) 2015-03-04 2020-12-30 Jitsubo Co., Ltd. Peptide synthesis method
EP3672601B1 (en) * 2017-09-25 2023-09-13 Sarepta Therapeutics, Inc. Processes for preparing phosphorodiamidate morpholino oligomers via fast-flow synthesis
CN112384520B (zh) * 2018-05-10 2024-06-11 日本新药株式会社 寡核苷酸化合物的制造方法

Similar Documents

Publication Publication Date Title
EP2922859B1 (en) Phosphonucleosides useful in the treatment of viral disorders
CA2623522C (en) Modified 4'-nucleosides as antiviral agents
JP3421335B2 (ja) 鏡像異性的に純粋なβ−D−(−)−ジオキソラン−ヌクレオシド
AU2018200461B2 (en) Process methods for phosphatidylinositol 3-kinase inhibitors
US6194398B1 (en) Phosphonate nucleotide compound
JPWO2021095874A5 (https=)
PT821690E (pt) Análogos de nucleotídeos para tratamento de infeções virais
US20140275508A1 (en) Artificial nucleic acids
PT2623507T (pt) Derivado de ácido morfolino-nucleico
WO2020017085A1 (ja) アルコキシフェニル誘導体、ヌクレオシド保護体およびヌクレオチド保護体、オリゴヌクレオチド製造方法、ならびに、置換基除去方法
RU2009104764A (ru) Производные пурина, как антангонисты a2a
JP2014516923A5 (https=)
JP2025128175A (ja) オリゴ核酸化合物の製造方法
SG191841A1 (en) Methods of making hiv attachment inhibitor prodrug compound and intermediates
JP2015509836A5 (https=)
JPWO2019216433A1 (ja) オリゴ核酸化合物の製造方法
JPH07503453A (ja) 抗ウイルス性非環式ホスホノメトキシアルキル置換アルケニル及びアルキニルプリン及びピリミジン誘導体
JPWO2021095875A5 (https=)
CN1921867B (zh) 用于治疗hiv感染的膦酸核苷衍生物
JP2011136905A (ja) ベンゼン化合物及びその医薬用途
WO2021095875A1 (ja) オリゴ核酸化合物の製造方法
CN1227489A (zh) 腺嘌呤核苷脱氨酶抑制剂
WO2022230954A1 (ja) オリゴ核酸化合物の製造方法
KR20070073958A (ko) 디플루오로뉴클레오시드 및 이의 제조 방법
US20080318904A1 (en) Deuterium-enriched tenofovir